Literature DB >> 20623136

Changing biochemical presentation of primary hyperparathyroidism.

Martin Almquist1, Anders Bergenfelz, Hans Mårtensson, Mark Thier, Erik Nordenström.   

Abstract

PURPOSE: Patients with primary hyperparathyroidism, pHPT, present with milder symptoms than previously. Some, but not all studies, suggest that this change in clinical pattern also implies lower preoperative parathyroid hormone (PTH) and/or calcium levels and smaller adenomas. This is important since reports indicate that smaller adenomas are more difficult to detect on preoperative imaging, possibly increasing the risk of surgical failure.
METHODS: There were 640 patients with histologically confirmed single-gland pHPT identified in a prospectively collected database. Median values of preoperative calcium, PTH, as well as adenoma weight were compared in three different time periods: 1990-1995, 1996-2000, and 2000-2007. Correlation between the preoperative levels of calcium and PTH and adenoma weight was calculated.
RESULTS: Preoperative ionized calcium decreased significantly over time (p < 0.001). There was a positive correlation between preoperative PTH and adenoma weight (r = 0.32, p < 0.001). The magnitude of this correlation decreased over time. In women, adenoma weight decreased significantly over time (p = 0.03). Median (25th-75th percentile) adenoma weight in women was 750 (400-1,380) mg, 650 (350-1,205) mg, and 520 (305-1,065) mg in the first, second, and third period, respectively.
CONCLUSION: From 1990 to 2007, there was a significant trend to operate pHPT patients with lower preoperative serum ionized calcium levels. In women, the adenoma weight decreased. This trend could potentially lead to decreased sensitivity in preoperative localization procedures.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20623136     DOI: 10.1007/s00423-010-0675-5

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  16 in total

Review 1.  Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century.

Authors:  John P Bilezikian; John T Potts; Ghada El-Hajj Fuleihan; Michael Kleerekoper; Robert Neer; Munro Peacock; Jonas Rastad; Shonni J Silverberg; Robert Udelsman; Samuel A Wells
Journal:  J Clin Endocrinol Metab       Date:  2002-12       Impact factor: 5.958

Review 2.  Imaging for primary hyperparathyroidism--an evidence-based analysis.

Authors:  Radu Mihai; Dietmar Simon; Per Hellman
Journal:  Langenbecks Arch Surg       Date:  2009-07-10       Impact factor: 3.445

3.  The predictive value of laboratory findings in patients with primary hyperparathyroidism.

Authors:  Géza Mózes; Kathleen J Curlee; Charles M Rowland; Jon A van Heerden; Geoffrey B Thompson; Clive S Grant; David R Farley
Journal:  J Am Coll Surg       Date:  2002-02       Impact factor: 6.113

4.  Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study.

Authors:  B Moosgaard; P Vestergaard; L Heickendorff; F Melsen; P Christiansen; L Mosekilde
Journal:  Eur J Endocrinol       Date:  2006-08       Impact factor: 6.664

5.  The impact of sestamibi scanning on the outcome of parathyroid surgery.

Authors:  John Allendorf; Lucy Kim; John Chabot; Mary DiGiorgi; Katherine Spanknebel; Paul LoGerfo
Journal:  J Clin Endocrinol Metab       Date:  2003-07       Impact factor: 5.958

6.  Impact of modern techniques on short-term outcome after surgery for primary hyperparathyroidism: a multicenter study comprising 2,708 patients.

Authors:  Anders O J Bergenfelz; Svante K G Jansson; Göran K Wallin; Hans G Mårtensson; Lars Rasmussen; Håkan L O Eriksson; Eva I M Reihnér
Journal:  Langenbecks Arch Surg       Date:  2009-07-18       Impact factor: 3.445

7.  Successful minimally invasive surgery in primary hyperparathyroidism after combined preoperative ultrasound and computed tomography imaging.

Authors:  T J van Vroonhoven; A van Dalen
Journal:  J Intern Med       Date:  1998-06       Impact factor: 8.989

8.  Patients with primary hyperparathyroidism operated on over a 24-year period: temporal trends of clinical and laboratory findings.

Authors:  M Palmér; S Ljunghall; G Akerström; H O Adami; R Bergström; L Grimelius; C Rudberg; H Johansson
Journal:  J Chronic Dis       Date:  1987

9.  The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years.

Authors:  Mishaela R Rubin; John P Bilezikian; Donald J McMahon; Thomas Jacobs; Elizabeth Shane; Ethel Siris; Julia Udesky; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2008-06-10       Impact factor: 5.958

Review 10.  Surgical strategy for sporadic primary hyperparathyroidism an evidence-based approach to surgical strategy, patient selection, surgical access, and reoperations.

Authors:  Radu Mihai; Marcin Barczynski; Maurizio Iacobone; Antonio Sitges-Serra
Journal:  Langenbecks Arch Surg       Date:  2009-06-25       Impact factor: 3.445

View more
  16 in total

1.  Surgical endocrinology--update 2010.

Authors:  Bruno Niederle
Journal:  Langenbecks Arch Surg       Date:  2010-08-16       Impact factor: 3.445

Review 2.  SPECT/CT: an update on technological developments and clinical applications.

Authors:  Michael Ljungberg; P Hendrik Pretorius
Journal:  Br J Radiol       Date:  2017-01-16       Impact factor: 3.039

3.  Use of Calcium and Parathyroid Hormone Nomogram to Distinguish Between Atypical Primary Hyperparathyroidism and Normal Patients.

Authors:  Olga A Lavryk; Allan E Siperstein
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

Review 4.  A meta-analysis comparing the biochemistry of primary hyperparathyroidism in youths to the biochemistry of primary hyperparathyroidism in adults.

Authors:  Jeffrey Roizen; Michael A Levine
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

5.  The small abnormal parathyroid gland is increasingly common and heralds operative complexity.

Authors:  Kelly L McCoy; Naomi H Chen; Michaele J Armstrong; Gina M Howell; Michael T Stang; Linwah Yip; Sally E Carty
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

6.  Biochemical Profile Affects IoPTH Kinetics and Cure Rate in Primary Hyperparathyroidism.

Authors:  F Fausto Palazzo
Journal:  World J Surg       Date:  2020-02       Impact factor: 3.352

7.  Presentation and Outcomes After Surgery for Primary Hyperparathyroidism During an 18-Year Period.

Authors:  Mark Thier; Erik Nordenström; Anders Bergenfelz; Martin Almquist
Journal:  World J Surg       Date:  2016-02       Impact factor: 3.352

Review 8.  Primary hyperparathyroidism in children and adolescents.

Authors:  Jeffrey Roizen; Michael A Levine
Journal:  J Chin Med Assoc       Date:  2012-08-21       Impact factor: 2.743

9.  Impaired calcium sensing distinguishes primary hyperparathyroidism (PHPT) patients with low bone mineral density.

Authors:  Thomas J Weber; James Koh; Samantha M Thomas; Joyce A Hogue; Randall P Scheri; Sanziana A Roman; Julie A Sosa
Journal:  Metabolism       Date:  2017-06-19       Impact factor: 8.694

10.  THE VOLUME OF SOLITARY PARATHYROID ADENOMA IS RELATED TO PREOPERATIVE PTH AND 25OH-D3, BUT NOT TO CALCIUM LEVELS.

Authors:  A Gatu; C Velicescu; A Grigorovici; R Danila; V Muntean; S J Mogoş; V Mogoş; C Vulpoi; C Preda; D Branisteanu
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Oct-Dec       Impact factor: 0.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.